Professional-grade semaglutide from reputable manufacturers like Shaanxi Hongda Phytochemistry maintains a purity level of 98% as verified by LC-MS testing, with residual solvents kept below 5ppm and moisture content under 0.5%
No study has shown BPC-157 promoting tumor growth, but the concern is noted in reviews (Sikiric et al., 2014) FDA status -- added to restricted compounding list in 2024
Favorable results from cardiovascular outcome trials, demonstrating significant major adverse cardiovascular events (MACE) reduction, have been crucial
17 In addition to these findings, the SUSTAIN-6 trial also showed that semaglutide can offer a significant reduction in the risk of new or worsening nephropathy including persistent macroalbuminuria, increase in serum creatinine or the need of renal replacement therapy
Cardiovasc Diabetol 21 , 169 (2022)